Skip to main content
    I

    iRhythm Technologies Inc (IRTC)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $90.83
    -1.08 (-1.18%)

    Market Cap: $3.05B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    iRhythm Technologies Inc (IRTC) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    iRhythm Technologies (IRTC) is expected to report earnings on Feb 17, 2027. In the quarter ended Sep 30, 2026, iRhythm Technologies reported EPS of $0.82. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    49%(18/37)
    Avg Surprise
    +0.87%
    Streak
    3 Q

    Upcoming Estimates

    Reports Feb 17, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.16
    Range$0.05 - $0.31
    18 analysts
    Revenue Consensus
    $252.87M
    Range$241.08M - $263.13M
    18 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.12
    Range-$0.35 - $0.23
    10 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago-$0.15+22.2%
    60d ago-$0.19+40.1%
    30d ago-$0.20+42.3%
    7d ago-$0.20+42.3%
    Current-$0.12
    Revenue Consensus
    $243.49M
    Range$237.60M - $256.67M
    12 analysts

    Next Report

    IRTC has an expected report date of Feb 17, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 5.9% below the $0.17 reported for the quarter ended Dec 31, 2025.

    IRTC Earnings Call

    The latest IRTC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 37 quarters below that had an estimate, IRTC beat 18, missed 17 and matched 2. Revenue for the quarter ended Sep 30, 2026 was $221.59M, up 14.9% from $192.88M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.82$0.02-$0.08 - $0.14N/AN/AN/A11N/ANov 5, 2026$221.59M
    Jun 30, 2026$0.58-$0.01-$0.10 - $0.12N/AN/AN/A100 up, 0 downAug 6, 2026$224.17M
    Mar 31, 2026-$0.35-$0.64-$0.90 - -$0.47+45.31%BeatN/A103 up, 5 downApr 30, 2026$199.39M
    Dec 31, 2025$0.17$0.01-$0.11 - $0.27N/AN/A+1600.0%111 up, 2 downFeb 19, 2026$208.89M
    Sep 30, 2025-$0.06-$0.28-$0.47 - -$0.12+78.57%BeatN/A122 up, 2 downOct 30, 2025$192.88M
    Jun 30, 2025-$0.32-$0.47-$0.63 - -$0.33+31.91%BeatN/A92 up, 4 downJul 31, 2025$186.69M
    Mar 31, 2025-$0.95-$0.94-$1.20 - -$0.68-1.06%MissN/A81 up, 0 downMay 1, 2025$158.68M
    Dec 31, 2024$0.01-$0.28-$0.52 - -$0.03+103.57%BeatN/A90 up, 1 downFeb 20, 2025$164.32M
    Sep 30, 2024-$1.26-$0.57-$0.67 - -$0.46-121.05%MissN/A90 up, 1 downOct 30, 2024$147.54M
    Jun 30, 2024-$0.61-$0.88-$1.05 - -$0.78+30.68%BeatN/A101 up, 0 downAug 1, 2024$148.05M
    Mar 31, 2024-$1.23-$0.99-$1.31 - -$0.70-24.24%MissN/A81 up, 0 downMay 2, 2024$131.93M
    Dec 31, 2023-$1.26-$0.60-$0.81 - -$0.25-110.00%MissN/A80 up, 0 downFeb 22, 2024$132.51M
    Sep 30, 2023-$0.79-$0.58-$0.75 - -$0.55-36.21%MissN/A81 up, 0 downNov 2, 2023$124.60M
    Jun 30, 2023-$0.43-$0.75-$0.99 - -$0.62+42.67%BeatN/A80 up, 0 downAug 3, 2023$124.13M
    Mar 31, 2023-$1.10-$0.86-$1.15 - -$0.73-27.91%MissN/A100 up, 0 downMay 4, 2023$111.44M
    Dec 31, 2022-$0.67-$0.62-$0.74 - -$0.57-8.06%MissN/A110 up, 0 downFeb 23, 2023$112.62M
    Sep 30, 2022-$0.63-$0.81-$0.88 - -$0.79+22.22%BeatN/A100 up, 0 downNov 1, 2022$103.88M
    Jun 30, 2022-$0.79-$0.90-$1.01 - -$0.81+12.22%BeatN/A91 up, 0 downAug 4, 2022$102.05M
    Mar 31, 2022-$0.80-$1.06-$1.21 - -$0.90+24.53%BeatN/A91 up, 0 downMay 5, 2022$92.38M
    Dec 31, 2021-$1.10-$1.17-$1.27 - -$0.69+5.98%BeatN/A91 up, 0 downFeb 23, 2022$81.80M
    Sep 30, 2021-$0.81-$1.07-$1.19 - -$1.01+24.30%BeatN/A9N/ANov 4, 2021$85.43M
    Jun 30, 2021-$0.59-$0.94-$1.10 - -$0.76+37.23%BeatN/A10N/AAug 5, 2021$81.28M
    Mar 31, 2021-$0.95-$0.85-$1.18 - -$0.40-11.76%MissN/A10N/AMay 6, 2021$74.31M
    Dec 31, 2020-$0.33-$0.31-$0.49 - -$0.10-6.45%MissN/A11N/AFeb 25, 2021$78.81M
    Sep 30, 2020-$0.17-$0.52-$0.73 - -$0.26+67.31%BeatN/A11N/ANov 5, 2020$71.94M
    Jun 30, 2020-$0.75-$0.75-$1.13 - -$0.530.00%In lineN/A9N/AAug 6, 2020$50.88M
    Mar 31, 2020-$0.34-$0.59-$0.78 - -$0.40+42.37%BeatN/A9N/AMay 7, 2020$63.53M
    Dec 31, 2019-$0.65-$0.50-$0.61 - -$0.40-30.00%MissN/A8N/AFeb 27, 2020$59.10M
    Sep 30, 2019-$0.74-$0.39-$0.44 - -$0.37-89.74%MissN/A7N/ANov 5, 2019$54.67M
    Jun 30, 2019-$0.46-$0.44-$0.48 - -$0.39-4.55%MissN/A8N/AJul 31, 2019$52.44M
    Mar 31, 2019-$0.33-$0.48-$0.56 - -$0.37+31.25%BeatN/A8N/AMay 7, 2019$48.33M
    Dec 31, 2018-$0.48-$0.45-$0.51 - -$0.37-6.67%MissN/A9N/AFeb 12, 2019$41.78M
    Sep 30, 2018-$0.43-$0.45-$0.50 - -$0.39+4.44%BeatN/A9N/AOct 30, 2018$38.44M
    Jun 30, 2018-$0.51-$0.39-$0.48 - -$0.34-30.77%MissN/A8N/AAug 1, 2018$35.29M
    Mar 31, 2018-$0.47-$0.36-$0.44 - -$0.22-30.56%MissN/A8N/AMay 2, 2018$31.76M
    Dec 31, 2017-$0.48-$0.35-$0.38 - -$0.32-37.14%MissN/A6N/AFeb 14, 2018$28.80M
    Sep 30, 2017-$0.29-$0.32-$0.33 - -$0.23+9.38%BeatN/A4N/ANov 1, 2017$25.04M
    Jun 30, 2017-$0.29-$0.29-$0.31 - -$0.260.00%In lineN/A4N/AAug 2, 2017$23.85M
    Mar 31, 2017-$0.24-$0.35N/A+31.43%BeatN/AN/AN/AMay 3, 2017$21.44M
    Dec 31, 2016-$0.37-$0.27N/A-37.04%MissN/AN/AN/AFeb 15, 2017$18.70M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.16, after -$3.09 the year before. It was -$3.17 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.16N/A
    Dec 31, 2024-$3.09N/A
    Dec 31, 2023-$3.58N/A
    Dec 31, 2022-$2.89N/A
    Dec 31, 2021-$3.45N/A
    Dec 31, 2020-$1.59N/A
    Dec 31, 2019-$2.18N/A
    Dec 31, 2018-$1.89N/A
    Dec 31, 2017-$1.30N/A
    Dec 31, 2016-$3.17N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,500 words across 18 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,53618
    2026Q2Jun 30, 20269,42018
    2026Q1Mar 31, 20267,95516
    2025Q4Dec 31, 20258,80017
    2025Q3Sep 30, 20257,61916
    2025Q2Jun 30, 20258,33515
    2025Q1Mar 31, 20258,86315
    2024Q4Dec 31, 20248,70316

    2026Q3 Earnings Call

    Opening remarks

    Francis Pruell Head of Strategic Finance and Investor Relations Thank you, operator, and thank you all for joining iRhythm's third quarter 2026 earnings call. With me today are Quentin Blackford, iRhythm's President and Chief Executive Officer; and Dan Wilson, our Chief Financial Officer. Before we begin, please note that management will make forward-looking statements within the meaning of federal securities laws under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding our intentions, beliefs, and expectations about future events, strategy, competition, products, operating plans, and performance. Forward-looking statements on this call are based on current estimates and assumptions, involve risks and uncertainties, and actual results may differ materially. These statements are made as of today, November 5, 2026, and are time sensitive. We undertake no obligation to update or revise them, except as required by law. Accordingly, you should not place undue reliance on these statements. For a discussion of risks and uncertainties, please refer to our most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and other filings with the SEC. Additionally, during the call, we will discuss certain financial measures that have not been prepared in accordance with GAAP. Unless otherwise noted, all references to financial measures on this call are presented on a non-GAAP basis. These non-GAAP measures should not be considered in isolation or as a substitute for or superior to GAAP results. Reconciliations to the most directly comparable GAAP measures can be found in our earnings release and the slides accompanying today's call. And with that, I'll turn the call over to Quentin.

    Quentin Blackford President and Chief Executive Officer Good afternoon, everyone, and thank you for joining us for our third quarter earnings call. We are pleased with iRhythm's progress in the quarter, and our results reflect the positive growth trajectory of our business across multiple channels as well as the meaningful operating leverage we continue to generate as we scale the Zio platform. I'll begin with the key highlights from the quarter and provide updates on our strategic priorities before turning the call over to Dan for a more detailed review of our financial results and outlook. Third quarter revenue was $221.6 million, up nearly 15% year-over-year against our toughest comparison of the year as we lap more than 30% growth in the third quarter of 2025. Overall performance was consistent with our guidance, with our core Zio Monitor business again outperforming our expectations. That monitor business continues to be driven by durable demand and sustained momentum across primary care, innovative channels, and international markets. We continue to expand the cardiac diagnostics market, both within traditional cardiology settings and across these underpenetrated opportunities.

    Frequently Asked Questions About IRTC

    When is iRhythm Technologies's next earnings date?

    iRhythm Technologies's next earnings report is expected for Feb 17, 2027.

    What EPS do analysts expect from IRTC next quarter?

    The consensus EPS estimate for iRhythm Technologies for the quarter ending Dec 31, 2026 is $0.16 from 18 analysts, with estimates from $0.05 to $0.31.

    How often does IRTC beat earnings estimates?

    iRhythm Technologies beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +17.96%.